Cardiometabolic Care: Advances, Investment and a New Era

October 14, 2026
Therapeutics, Diagnostics & Med Device Innovation
For decades, cardiometabolic disease has sat outside the core focus of women's health. Advances in diagnostics, growing insight into sex-specific risk, and the rise of metabolic health as a clinical and commercial priority are beginning to change that. This session explores where meaningful progress is being made, how understanding of cardiometabolic health in women is evolving, and what this means for this defining opportunity to improve outcomes and reshape women's health for the long term.
Speakers
Nisha Parikh
Nisha Parikh, System Director, Women's Heart Program, Department of Cardiology - Northwell Health
Professor Rachel Batterham
Professor Rachel Batterham, SVP Medical Innovation & External Engagement Global Cardiometabolic Health - Eli Lilly & Company